Biotech/Biomedical
News Category

Quantum BioPharma's $12.22M War Chest Fuels Lucid-MS Phase 2 Trial in Progressive MS
Quantum BioPharma's improved liquidity and reduced losses position it to advance its Lucid-MS Phase 2 trial for progressive multiple sclerosis, a key ...

MindBio's AI Voice Analytics Achieves Up to 83% Accuracy in Intoxication Detection, Eyes Commercial Pilot
MindBio Therapeutics reports up to 83% accuracy in AI-driven intoxication detection and announces a CA$350,000 private placement to support commercial...

CNS Pharmaceuticals Narrows Q3 Loss, Targets First Pipeline Deal by Year-End 2026
CNS Pharmaceuticals reported a narrowed third-quarter net loss and a stronger cash position as it pursues its first pipeline-building transaction by t...

Helus Pharma's Widening Q2 Loss Masks a Phase 3 Milestone That Could Reshape Depression Treatment
Helus Pharma's fiscal Q2 2027 results show a ballooning net loss driven by Phase 3 spending, but completing enrollment in its pivotal APPROACH study m...

Quantum Computing's Promise for Drug Discovery Tempered by Technical Hurdles
Quantum computing could revolutionize drug discovery by solving complex molecular problems, but significant technical challenges must be overcome befo...

Personalized Vaccines Extend Survival in Glioblastoma, Spurring Industry Investment
Personalized vaccines are showing promise in extending survival for glioblastoma patients, and companies like CNS Pharmaceuticals are investing in nex...

Grand Mirrors Secures UL Recognition, Giving Architects and Designers a New Technical Benchmark for Illuminated Mirrors
Grand Mirrors has achieved UL Recognition under File Number E552871 for evaluated components of its illuminated mirrors, a credential that gives speci...

SS Innovations Elevates Srivastava to President, Names Gary Lo CFO to Drive U.S. Expansion
SS Innovations International has promoted Dr. Vishwa Srivastava to president and appointed Gary Lo as CFO, strengthening its leadership team as it nav...

Ohio Wastewater Study Signals New Era for Community Health Monitoring
A recent Ohio study demonstrating that wastewater can reveal community-wide health patterns opens the door to proactive public health surveillance and...

Creative Biolabs Highlights Complementary RNA Profiling Methods to Overcome Single-Cell Research Blind Spots
Creative Biolabs emphasizes three distinct RNA analysis approaches—scRNA-seq, snRNA-seq, and smFISH—to help researchers address sample-specific challe...

MedRhythms and Vascudyne Take Top Honors at AHA Health Tech Competition
The American Heart Association's Health Tech Competition awarded MedRhythms and Vascudyne for innovations in stroke rehabilitation and bioengineered b...

Lonza CEO Wolfgang Wienand to Present at Jefferies Global Healthcare Conference
Lonza CEO Wolfgang Wienand will present at the Jefferies Global Healthcare Conference in London, offering investors a live webcast and 90-day replay o...

Viromed Medical AG Gains Early Approval for ViroCAP® med in Turkey, Accelerating International Expansion
Viromed Medical AG has received approval for its ViroCAP® med cold plasma device in Turkey ahead of schedule, unlocking binding orders and advancing i...

Heidelberg Pharma to Present New Clinical Data on ATAC Candidates at ASH 2026
Heidelberg Pharma will present new clinical data on its ATAC candidates, including the first recommended Phase 2 dose for pamlectabart tismanitin and ...

Adaptogenics Health Corp. Sees Peptide Market Shift as Federal Policy Opens Pharmacy and Telehealth Channels
A proposed federal interim peptide access policy could allow specialty pharmacies to produce certain peptides, creating new opportunities for Adaptoge...

Tonix Pharmaceuticals to Present at Guggenheim Healthcare Innovation Conference, Highlighting Pipeline and Commercial Growth
Tonix Pharmaceuticals' upcoming presentation at the Guggenheim conference underscores its progress in CNS and immunology, including its newly approved...

Quantum BioPharma Targets Neurological Disorders with Multi-Pronged Strategy
Quantum BioPharma advances a diversified approach combining drug development, consumer wellness, and royalty partnerships to address neurological cond...

Election Anxiety, AI Doubts and Global Bond Stress Collide in Markets
The latest DH Unplugged episode examines how a potential Democratic blue wave, mounting AI spending concerns and France's bond selloff are creating cr...

Quantum BioPharma's Unbuzzd Draws Mainstream Attention as Placebo-Controlled Trial Shows Early Promise
Quantum BioPharma's unbuzzd supplement, designed to support alcohol metabolism, gained mainstream attention after Men's Fitness highlighted promising ...

Helus Pharma to Present at Guggenheim Healthcare Innovation Conference
Helus Pharma's CEO will participate in a fireside chat at a major healthcare investment conference, offering investors a chance to hear about the comp...

Kairos Pharma's ENV-105 Shows Significant Progression-Free Survival Benefit in Prostate Cancer Trial
Kairos Pharma's ENV-105 demonstrated a statistically significant improvement in median progression-free survival for metastatic castration-resistant p...

Ultrasound Method for Brain Cancer Treatment Shows Promise as Companies Race for Better Therapies
University of Virginia researchers have developed an experimental ultrasound method to deliver therapeutic nanoparticles into the brain to fight gliob...

SS Innovations Demonstrates Long-Distance Robotic Cardiac Surgery, Highlighting Potential to Extend Specialist Care
SS Innovations showcased its SSi Mantra system by performing remote robotic cardiac and other surgeries across thousands of miles, underscoring the po...

Adaptogenics Health Corp. Targets Supply, Verification, and Traceability in Emerging Peptide Market
Adaptogenics Health Corp. is building its peptide strategy around proof of what is in each vial, as the FDA and HHS push for a regulated peptide marke...

Quantum BioPharma's Unbuzzd Draws Men's Fitness Attention as Trial Shows Early Promise
Quantum BioPharma's unbuzzd supplement, tested in a placebo-controlled trial, has been highlighted by Men's Fitness for its promising early results, p...

HeartBeam's ALIGN-ACS Pilot Study Shows Higher Specificity Than Standard ECG for Heart Attack Assessment
HeartBeam's positive ALIGN-ACS pilot study results, showing higher specificity and comparable sensitivity to standard ECGs for acute coronary syndrome...

Mayo Clinic Study Finds Cerebrospinal Fluid Harbors DNA of Complex Brain Tumors, Opening New Avenue for Less Invasive Diagnosis
A Mayo Clinic study reveals that cerebrospinal fluid contains DNA from complex brain tumors, offering a safer, less invasive alternative to traditiona...

ABVC BioPharma Closes $3.39 Million Convertible Note Offering to Fund Operations and Settle Lind Claim
ABVC BioPharma's $3.39 million private placement of senior convertible notes provides working capital and settles a $625,000 claim with Lind Global Fu...

tZERO to Go Public via SPAC Merger, Valuing Tokenization Infrastructure at $350 Million
tZERO's planned business combination with FG Imperii Acquisition Corp. will take the tokenization infrastructure provider public at a $350 million pre...

Large Israeli Study Finds Modern Hormone Therapy Not Tied to Heart Disease Risk
A 12-year study of over 52,000 women in Israel found that contemporary hormone replacement therapy did not increase the risk of heart attack, stroke, ...

Tonix Pharmaceuticals Appoints George Lederman to Lead AI and Strategic Transformation
Tonix Pharmaceuticals appoints George Lederman as EVP of Strategy and Transformation to drive AI initiatives and business development, a move that cou...

AI and Wearables Could Predict Hypertensive Crisis Days in Advance
Preliminary research suggests AI analysis of blood pressure monitor and fitness tracker data can predict hypertensive crises up to three days early, p...

Okogen Doses First Patient in EMERALD Trial, Advancing Treyegen Toward a New Treatment Approach for Acute Infectious Conjunctivitis
Okogen has dosed the first patient in its Phase 1/2 EMERALD trial of Treyegen, a potential single therapy for acute infectious conjunctivitis, marking...

Heart Valve Disease Deaths Reverse Decades-Long Decline, Projected to Stay Elevated Through 2040
New preliminary research shows that after nearly two decades of decline, death rates from valvular heart disease among U.S. adults 65 and older have r...

Survey Reveals Low Adoption of New CKM Syndrome Tools in U.S. Clinics
A survey of 97 clinical sites found that while most screen for individual heart, kidney, and metabolic risks, fewer than one-third use comprehensive C...

New Analysis Raises Annual Nonmelanoma Skin Cancer Diagnoses to 4.7 Million in the U.S.
A new analysis estimates that 4.7 million Americans are diagnosed with nonmelanoma skin cancer each year, 42% more than previously reported, highlight...

TransCode Therapeutics Launches Strategic Review to Maximize Value of Oncology Portfolio
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing value, including potential licensing, partnerships, ...

Cedars-Sinai Team Wins American Heart Association Grant to Build AI Early Warning System for Sudden Cardiac Arrest
A new American Heart Association grant to Cedars-Sinai researchers will fund development of an AI-powered early warning system that combines wearable,...

SeABank's New Sustainable Finance Framework Signals Major Push for Green and Blue Lending in Vietnam
SeABank's Sustainable Finance Framework, backed by an S&P Global Ratings second-party opinion, unifies green, blue, and social financing to accelerate...

Enodia Therapeutics Names Henrik Torp Nielsen as CFO to Drive Growth and Advance Sec61 Platform
Enodia Therapeutics has appointed Henrik Torp Nielsen as Chief Financial Officer to lead financial strategy as the company advances its proprietary Se...

Certified-PEP Publishes 2026 Research Peptide Supplier Comparison
Certified-PEP's 2026 comparison of 10 research peptide suppliers highlights the importance of batch-specific Certificates of Analysis and transparent ...

Dr. Leonard Hochstein Grant Highlights 30-Year Career and Patient-Centered Approach
The Dr. Leonard Hochstein Grant recognizes its namesake's three-decade plastic surgery career, emphasizing his surgical volume, international patient ...

Hallstat Moves Foley Catheter Manufacturing Closer to U.S. Ahead of Market Launch
Hallstat's plan to relocate manufacturing for its CAUTI-reducing Foley catheter system to the U.S. or nearby countries aims to cut costs, shorten ship...

Creative Biolabs Highlights Tumor Organoid Co-Culture Models for CAR-T Research
Creative Biolabs' tumor organoid co-culture models offer a more physiologically relevant 3D platform for evaluating CAR-T cell activity, addressing a ...

Creative Biolabs Launches Dual-Vesicle Platform to Tackle CAR-T Barriers in Solid Tumors
Creative Biolabs has introduced an integrated OMV and exosome-boosted CAR-T development platform to help researchers address poor infiltration, immuno...

GeoVax Secures $1 Million Revolving Loan, Board Shakeup Follows
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, leading to a major board restructuring that could impact t...
